logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • HMG-CoA Reductase Inhibitor class drugs

    FiltersReset Filters
    19 results

    • atorvastatin calcium

      (Atorvastatin calcium)
      NIVAGEN PHARMACEUTICALS, INC.
      Usage: Atorvastatin calcium is indicated to reduce the risk of myocardial infarction, stroke, and angina in at-risk adults. It also lowers LDL cholesterol in adults with hyperlipidemia, heterozygous or homozygous familial hypercholesterolemia, and treats primary dysbetalipoproteinemia and hypertriglyceridemia as an adjunct to diet.

    • caduet

      (amlodipine besylate and atorvastatin calcium)
      Pfizer Laboratories Div Pfizer Inc
      Usage: CADUET (amlodipine and atorvastatin) is indicated for patients requiring both hypertension management and lipid control. Amlodipine treats high blood pressure and various types of angina, while atorvastatin reduces risk of cardiovascular events and lowers LDL cholesterol in hyperlipidemia.

    • crestor

      (Rosuvastatin)
      AstraZeneca Pharmaceuticals LP
      Usage: CRESTOR is indicated for reducing the risk of major cardiovascular events in adults at increased risk, as an adjunct to diet for lowering LDL cholesterol in various hyperlipidemias, and for treating primary dysbetalipoproteinemia and hypertriglyceridemia in adults. It is also used in pediatric patients with familial hypercholesterolemia.

    • ezetimibe and simvastatin

      (Ezetimibe and Simvastatin)
      AvKARE
      Usage: Ezetimibe and simvastatin tablets are indicated as adjunct therapy to diet for reducing cholesterol and triglyceride levels in patients with primary or mixed hyperlipidemia, including homozygous familial hypercholesterolemia. They are part of a comprehensive approach to reduce the risk of atherosclerotic vascular disease.

    • fluvastatin sodium

      (Fluvastatin Sodium)
      Lannett Company, Inc.
      Usage: Fluvastatin sodium extended-release tablets are indicated for reducing the risk of coronary revascularization and slowing coronary atherosclerosis in adults with coronary heart disease. They also help lower LDL cholesterol in adults with primary hyperlipidemia and in pediatric patients aged 10 and older with heterozygous familial hypercholesterolemia.

    • lipitor

      (atorvastatin calcium)
      Viatris Specialty LLC
      Usage: LIPITOR is indicated to reduce the risk of myocardial infarction, stroke, and angina in adults with or without coronary heart disease risk factors. It also lowers LDL cholesterol in adults and children with primary hyperlipidemia, familial hypercholesterolemia, and other dyslipidemias as an adjunct to diet.

    • livalo

      (pitavastatin calcium)
      Kowa Pharmaceuticals America, Inc.
      Usage: LIVALO is indicated as an adjunct to diet for reducing low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia and in patients aged 8 years and older with heterozygous familial hypercholesterolemia (HeFH).

    • lovastatin

      (lovastatin)
      Lupin Pharmaceuticals, Inc.
      Usage: Lovastatin is indicated for lowering total and LDL cholesterol levels as part of a treatment strategy in individuals with dyslipidemia at risk for atherosclerotic vascular disease, including those with coronary heart disease and hypercholesterolemia. It is also used for primary prevention of coronary heart disease in certain populations.

    • rosuvastatin calcium

      (Rosuvastatin Calcium)
      Shandong New Time Pharmaceutical Co., Ltd.
      Usage: Rosuvastatin is indicated for reducing cardiovascular risk in adults without coronary heart disease, lowering LDL-C in various hyperlipidemia types, treating familial hypercholesterolemia in children and adults, and addressing primary dysbetalipoproteinemia and hypertriglyceridemia as an adjunct to diet and other therapies.

    • rosuvastatin calcium

      (Rosuvastatin Calcium)
      UMEDICA LABORATORIES PRIVATE LIMITED
      Usage: Rosuvastatin is indicated to reduce cardiovascular event risk in adults without coronary heart disease, lower LDL cholesterol in various forms of hyperlipidemia (primary, familial), and treat dysbetalipoproteinemia and hypertriglyceridemia as an adjunct to diet in both adults and pediatric patients aged 7 years and older.